B-type natriuretic peptide: a role in selection and follow up of the implantable cardioverter-defibrillator patient?. Issue 2 (13th January 2006)

• Record Type: Journal Article
• Authors: Anderson, M
• Is Part Of: Heart. Volume 92:Issue 2(2006)
• Page Start: 147
• Page End: 148
• Publication Date: 2006-01-13
• Subjects: ANP, atrial natriuretic peptide -- BNP, B-type natriuretic peptide -- CAD, coronary artery disease -- CHF, congestive heart failure -- CNP, C-type natriuretic peptide -- ICD, implantable cardioverter-defibrillator -- LV, left ventricular -- LVEF, left ventricular ejection fraction -- NICM, non-ischaemic cardiomyopathy -- NYHA, New York Heart Association; B-type natriuretic peptide -- BNP -- implantable cardioverter-defibrillator -- ICD; Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/hrt.2005.070888
• Languages: English
• ISSNs: 1355-6037

Abstract

Abstract : B-type natriuretic peptide may have a role in predicting the risk of ICD therapy, identifying patients with deteriorating clinical status and allowing them to be selected for more detailed medical review and, if necessary, drug treatment